See our coverage on
We will find cures for ALS. The only question is when. That answer depends on you.
Stay informed on I AM ALS’ progress and what you can do to help us make hope real.
I AM ALS statement on demographic data collection
We are writing this to respond to community questions about I AM ALS’ demographic data collection. In particular, there have been several frustrations with extensive gender identity and sexual orientation response options on action forms.
NurOwn Working Group creates social media toolkit for advocates
From now until September 27, I AM ALS and the ALS community will use the template social media posts to encourage people to submit written testimony for the NurOwn AdComm and support I AM ALS’ statement on NurOwn.
I AM ALS named as a finalist for PRWeek’s 2023 Purpose Awards
I AM ALS has been named as a PRWeek 2023 Purpose Award finalist.
I AM ALS announces grant from Poarch Band of Creek Indians
I AM ALS recently received a $250,000 grant from the Poarch Band of Creek Indians.
Guide to Submitting Written Testimony to the FDA about NurOwn
The FDA invites people to submit written comments about NurOwn to the AdComm panel for their review prior to the September 27th meeting.